A look at Google’s Med-PaLM 2 and what large language models mean for medicine, from search and software to the prospect of a chatbot as a first point of clinical contact.
Inscripta’s team on the bioeconomy: engineering yeast and bacteria in fermentation tanks to produce medicines, agricultural products and cosmetics at industrial scale.
1910 Genetics founder and CEO Jen Nwankwo on where machine learning genuinely speeds up drug discovery, from target identification through preclinical testing, and how startup funding has shifted.
Cry Me a Biomarker: Using Tears to Screen for Cancer…
Insilico Brings Generative AI to Drug Development and Discovery Episode…
Raphael Townshend on The Power of Small Molecule Drugs Episode…
How the Glaucomfleckens are Humanizing Medicine, One Laugh at a…
Stephen Kingsmore’s quest to test every baby with genome sequencing…